Hepatoma Research is Indexed in Embase

Published on: 2 Sep 2023 Viewed: 252

We are delighted to announce that Hepatoma Research has been indexed in the Embase Database in July, according to Elsevier. The inclusion in Embase marks a significant international recognition of the journal's dedication to facilitating the dissemination of high-quality research in the field of liver cancer.


With its newfound inclusion in Embase, it will enhances the global visibility of the journal's content. The journal aims to continue fostering innovative research and driving progress in the understanding and treatment of this complex cancer.

We would like to take this opportunity to express our heartfelt appreciation for the invaluable support extended to us by our Editorial Board members, the reviewers' team, the authors, and our readers. Their contributions have been instrumental in achieving this milestone. We expect the journal will achieve more advancements in the future through the collective efforts of everyone involved.

About Embase

Embase is a versatile, continuously updated, and highly comprehensive biomedical database. It encompasses significant international biomedical literature from 1947 to the present, and all articles have been thoroughly indexed using Elsevier's life science indexing tool, Embase Indexing, and Emtree®. Moreover, the entire database is easily accessible across multiple platforms. Embase plays a vital role in advancing biomedical knowledge and promoting groundbreaking research.

About Hepatoma Research

Hepatoma Research, an English-language academic journal founded by OAE Publishing Inc. In April 2015. It operates as a prestigious open-access publication with international peer review and continuous online publishing. As of 2022, it has achieved a CiteScore of 2.5 points and is currently indexed in databases such as ESCI, Scopus, CAS, and Dimensions. In June 2024, it is set to receive its inaugural impact factor. The journal primarily focuses on research related to the occurrence, development, diagnosis, and treatment of liver cancer. It offers authors a platform for scientific, efficient, and rapid publication services, while also providing scholars with a rich academic sharing and exchange platform.

Journal website:

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)


All published articles are preserved here permanently:


All published articles are preserved here permanently: